TLDR Alopecia areata is an autoimmune disorder causing hair loss and can impact mental health.
Alopecia areata was identified as an autoimmune disorder leading to inflammation-based hair loss, commonly seen in dermatological outpatient settings. It significantly affected patients' quality of life and could lead to psychological issues. The review covered the pathogenesis, clinical features, management principles, and highlighted key findings for differential diagnosis and future treatment considerations.
85 citations
,
October 2012 in “Dermatologic Clinics” Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.
1113 citations
,
August 1999 in “The New England Journal of Medicine” Hair follicle biology advancements may lead to better hair growth disorder treatments.
April 2019 in “International journal of research in dermatology” A child with rough nails also had hair loss and allergies.
37 citations
,
October 2017 in “Clinical and Experimental Dermatology” Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.
18 citations
,
January 2010 in “Dermatology Research and Practice” DPCP treatment for alopecia areata can sometimes cause vitiligo.